Access to the information and documents contained in the following pages may be illegal in certain countries and only certain categories of persons may be authorized to access this information and these documents. Any person who wishes to access the information and documents contained on this website must first satisfy himself/herself that he or she is not subject to local laws or regulations prohibiting or restricting such right of access or requiring registration or approval of the securities described herein. EUROAPI will not accept any liability arising out of the breach by any person of the applicable laws or regulations.




No securities are being offered for sale or subscription in connection with the distribution of EUROAPI’s shares and, accordingly, the information on this website does not constitute an offer to sell or to subscribe for or a solicitation of an offer to purchase or to subscribe for the shares described herein, especially in any jurisdiction in which such an offer or solicitation would be unlawful under the laws of that jurisdiction.


The securities of EUROAPI have not been and will not be registered under the U.S. Securities Act of 1933, as amended and neither Sanofi, nor EUROAPI intend to make a public offer of securities in the United States or any other jurisdiction.


The contents of this website include statements that are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including terms such as “believe”, “estimate”, “anticipate”, “expect”, “intend”, “may”, “will” or “should”, and include statements that EUROAPI makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. EUROAPI’s actual results may differ materially from those predicted.